SIFROL ER 4.5 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 4.5 MG

MAH:

RAFA LABORATORIES LTD

ATC_code:

N04BC05

pharmaceutical_form:

TABLETS EXTENDED RELEASE

administration_route:

PER OS

manufactured_by:

BOEHRINGER INGELHEIM PHARMA GmbH & CO.KG

therapeutic_group:

PRAMIPEXOLE

therapeutic_indication:

Treatment of signs and symptoms of idiopathic Parkinson’s disease, as monotherapy or in combination with lovodopa.

authorization_date:

2011-11-01